References

  1. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW. Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Lawrenceville, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.
  2. Chou R, Aronson N, Atkins D. Chapter 7. Assessing harms when comparing medical interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(11)-EHC063-EF. March 2011; http://www.effectivehealthcare.ahrq.gov. Accessed 06/20/2011.
  3. AHRQ Agency for Healthcare Research and Quality.  http://www.ahrq.gov/. Accessed 06/20/2011.
  4. Dawson B, Trapp RG. Basic & Clinical Biostatistics. Fourth edition. New York: Lange Medical Books/McGraw-Hill; 2004.
  5. Atkins D, Chang S, Gartlehner G. Chapter 6. Assessing the applicability of studies when comparing medical interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(11)-EHC063-EF. March 2011; http://www.effectivehealthcare.ahrq.gov. Accessed 06/20/2011.
  6. Glossary of terms in the Cochrane Collaboration. Version 4.2.5. Updated May 2005. 2005; http://www.cochrane.org/glossary. Accessed 06/20/2011.
  7. Strom BL. Pharmacoepidemiology. Chichester: John Wiley & Sons; 1994.
  8. Hill AB. The environment and disease: Association or causation? Proc R Soc Med. May 1965;58:295-300.
  9. Phillips CV, Goodman KJ. The missed lessons of Sir Austin Bradford Hill. Epidemiol Perspect Innov. 2004;1:3.
  10. IOM (Institute of Medicine). Finding what works in health care: standards for systematic reviews. Washington, DC: The National Academies Press; 2011.
  11. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193-206.
  12. IOM (Institute of Medicine). Initial national priorties for comparative effectiveness research. Washington, DC: The National Acadmies Press; 2009.
  13. Lohr KN. Emerging methods in comparative effectiveness and safety: symposium overview and summary. Med Care. 2007;45(10 Supl 2):S5-8.
  14. Effective Health Care Program. 2011; http://www.effectivehealthcare.ahrq.gov/. Accessed 06/10/2011.
  15. Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ.  2007;334:786.
  16. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, et al. Validity of composite end points in clinical trials. BMJ. 2005;330:594-596.
  17. Norris S, Atkins D, Bruening. Chapter 4. Selecting observational studies for comparing medical interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(11)-EHC063-EF. March 2011; http://www.effectivehealthcare.ahrq.gov. Accessed 06/20/2011.
  18. CONSORT transparent reporting of trials.  http://www.consort-statement.org/. Accessed 06/20/2011.
  19. Fayyad UM, Piatetsky-Shapiro G, Smyth P. From data mining to knowledge discovery: An overview. In: Fayyad UM, Piatesky-Shapiro G, Smyth P, Uthurusamy R, eds. Advances in Knowledge Discovery and Data Mining. Menlo Park, CA: MIT Press; 1996:1-34.
  20. About the DEcIDE Network.  http://www.effectivehealthcare.ahrq.gov/index.cfm/who-is-involved-in-the.... Accessed 06/20/2011.
  21. Light RJ, Pillemer DR. Summing Up:  The Science of Reviewing Research. Cambridge, MA: Harvard University Press; 1984.
  22. Effective Health Care Program.  http://www.effectivehealthcare.ahrq.gov/. Accessed 06/10/2011.
  23. Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol. 2006;59:1040-8.
  24. About the Eisenberg Center.  http://www.effectivehealthcare.ahrq.gov/index.cfm/who-is-involved-in-the.... Accessed 06/20/2011.
  25. Welcome to the EQUATOR Network website: the resource centre for good reporting of health research studies. 2011; http://www.equator-network.org/. Accessed 06/09/2011.
  26. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71-2.
  27. About Evidence-based Practice Centers (EPCs).  http://www.effectivehealthcare.ahrq.gov/index.cfm/who-is-involved-in-the.... Accessed 06/11/2011.
  28. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637-48.
  29. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
  30. Becker BJ. Failsafe N or file-drawer number, in In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester, UK: John Wiley & Sons, Ltd; 2006.
  31. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. West Sussex, UK: John Wiley & Sons, Ltd; 2009.
  32. Good ReseArch for Comparative Effectiveness.  http://www.graceprinciples.org/. Accessed 06/20/2011.
  33. Dreyer NA, Schneeweiss S, McNeil BJ, et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care. 2010;16:467-71.
  34. Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science. 1998;282:245-6.
  35. EBM Glossary.  http://www.medicine.ox.ac.uk/bandolier/glossary.html. Accessed 06/10/2011.
  36. Fu F, Gartlehner G, Grant M, et al. Chapter 9. Conducting quantitative synthesis when comparing medical interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(11)-EHC063-EF. March 2011; http://www.effectivehealthcare.ahrq.gov. Accessed 06/20/2011.
  37. Kerlinger FN. Foundations of behavioral research. Third ed. Fort Worth: Harcourt Brace Jovanovich College Publishers; 1986.
  38. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
  39. IOM (Institute of Medicine). Medicare: A strategy for quality assurance. Washington, DC: National Acadmy Press; 1990.
  40. Olson CM, Rennie D, Cook D, et al. Publication bias in editorial decision making. JAMA.  2002;287:2825-8.
  41. Taylor JR. An introduction to error analysis: The study of uncertainties in physical measurements. 2nd ed. Sausalito, CA: University Science Books; 1997.
  42. Gliklich RE, Dreyer NA. Registries for evaluating patient outcomes: A user's guide. AHRQ Publication No. 10-EHC049. 2nd ed. Rockville, MD: Effective Health Care Program; Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services; September 2010.
  43. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med.  1997;156(4 Pt 1):1032-9.
  44. Patient-Centered Outcomes Research Institute.  http://www.pcori.org/.
  45. Sox HC. Comparative effectiveness research: a progress report. Ann Intern Med. 2010;153:469-72.
  46. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med. 1997;127:380-7.
  47. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-94.
  48. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
  49. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-72.
  50. Lohr KN, Carey TS. Assessing "best evidence": issues in grading the quality of studies for systematic reviews. Jt Comm J Qual Improv. 1999;25:470-9.
  51. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. Boston: Houghton Mifflin; 1963.
  52. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston: Houghton Mifflin; 2002.
  53. Bjornson DC. Interpretation of drug risk and benefit: individual and population perspectives. Ann Pharmacother. Apr 2004;38(4):694-699.
  54. Owens DK, Lohr KN, Atkins D. Chapter 10. Grading the strength of a body of evidence when comparing medical interventions. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(11)-EHC063-EF. March 2011; http://www.effectivehealthcare.ahrq.gov. Accessed 06/20/2011.
  55. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-7.
  56. Clancy CM, Slutsky J. Preface, in Williams JW, Coeytaux R, Wang A, Glower DD. Percutaneous heart valve replacement. Technical Brief No. 2. (Prepared by Duke Evidence-based Practice Center under Contract No. 290-02-0025.). August 2010; www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed 06/20/2011.
  57. Woolf SH. The meaning of translational research and why it matters. JAMA. 2008;299:211-3.
  58. Sung NS, Crowley WF, Jr., Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-87.
  59. Duval S. The trim and fill method. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester, UK: John Wiley & Sons, Ltd; 2006.